ASCT Viewpoint
Mar. 11, 2015

ACIP: 9-valent HPV vaccine OK to use
MedPage Today
The CDC's Advisory Committee on Immunization Practices (ACIP) voted in favor of including the new 9-valent HPV strain vaccine in its recommendations about HPV immunization. And in other votes at the weather-shortened meeting here, the panel voted to recommend meningococcal group B vaccines only for high-risk groups, including individuals in "outbreak areas," and dialed back its recommendation of the live attenuated influenza vaccine (LAIV) to "no preference" compared to the inactive vaccine.More

Registration is now open for the 2015 ASCT Annual Conference

May 1-3, 2015
Sheraton Hotel
Nashville, Tennessee

Click here for detailed information and registration

Self-collected HPV testing viable option for cervical cancer screening
Self-collected HPV specimens may help detect cervical cancer sooner than cytology, according to study results. The self-collected method also may help reduce patient costs and boost coverage, researchers wrote. Although cytology-based screening has helped reduce the percentage of cervical cancers, it often must be repeated to help identify underlying abnormalities that eventually could prove to be cancerous. More

Groundbreaking research aims to provide more effective treatment for women with cervical cancer
News Medical
University of Huddersfield researcher Dr. Tsitsi Chituku is taking part in a project that seeks to learn more about the genetic factors that make some women more susceptible to cervical cancer. It was a recent visit to Africa, to carry out a health screening project involving hundreds of women, which helped to shape the emphasis of her research. More

An improved vaccination against a virus — and some cancers
The New York Times
Dr. Ronald A. DePinho likes to call the HPV shot series a "cancer vaccine." That's not, of course, strictly accurate. The HPV vaccine prevents the human papillomavirus, which sometimes goes away on its own, but can persist and cause cervical, vaginal, vulvar, penile, anal or oral cancer in women and men.More

HPV-positive oropharyngeal cancer has cure potential
Oncology Nurse Advisor
The time may have come to talk about a cure for some cases of metastatic oropharyngeal cancer caused by human papillomavirus. This is a remarkable development, given the disease's history of fatality. Sophie Huang, MRT(T), assistant professor in the Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, presented the details of a recent study at the International Conference on Innovative Approaches in Head and Neck Oncology in Nice, France. More

Recursive partitioning analysis forms new stages for HPV-related oropharyngeal cancer
Recursive partitioning analysis-based TNM stage groupings were associated with significantly improved survival prediction for patients with HPV-related non-metastatic oropharyngeal carcinomas, according to study results. Brian O’Sullivan, M.D., of Princess Margaret Hospital in Toronto, and colleagues evaluated data from patients with HPV-related and HPV-unrelated non-metastatic oropharyngeal cancer. Patients underwent radiation therapy with or without chemotherapy between 2000 and 2010. More

Dangerous infections now spreading outside hospitals
USA Today
Life-threatening infections caused by bacteria called Clostridium difficile now sicken nearly half a million Americans a year, health officials said. The number of these infections — which can cause "deadly diarrhea" and damage to the colon — doubled between 2000 and 2010, according to the Centers for Disease Control and Prevention. More